Navigation Links
AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annual Meeting
Date:4/14/2009

pliance program, international opportunities and challenges, and many more issues affecting smaller medical technology companies.

"I encourage all industry executives to attend this premier industry event and join MDMA and its member companies in our Nation's Capital" said Joe Kiani, Chairman and CEO of Masimo Corporation. "The meeting and congressional fly-in provide a unique opportunity for entrepreneurs to directly engage policymakers on Capitol Hill."

More information on the agenda, venue, accommodations and registration can be found online at www.medicaldevices.org, or by calling MDMA at (202) 354-7172. Members may attend for $795 and non members for $995. Medical Device Companies with sales under $500,000 can join MDMA by registering for the Annual Meeting at the non member rate. Register and start receiving member benefits today.

The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C. representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.


'/>"/>
SOURCE Medical Device Manufacturers Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
2. HealthInsuranceFinders.com Launches Video Contest for Young Directors
3. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
4. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
5. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
6. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
7. Nick Childs Joins Grey New York as Director of Content Development
8. New Director of Nursing Practice Named for Nurses Association
9. Patient Safety Authority Board of Directors Names Infection Advisory Panel
10. William Moore Appointed to IRIDEX Board of Directors
11. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... A Diet Doc in-house clinical study ... are turning back the clock on aging, looking younger ... the company has recently added their prescription anti-aging human ... prescription and non-prescription diet products and healthy living supplements. ... best anti-aging human growth hormone therapy to their ...
(Date:11/17/2014)... Oskaloosa, IA (PRWEB) November 17, 2014 ... featured in an upcoming episode of American Farmer airing ... Tuesday at 8:30 am ET on RFD-TV. , World ... organic plant based proteins. World Food’s unique system provides ... seed to protein ingredients. , This segment will educate ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 QuickChek customers ... their September “Dog Tag” Promotion. In total, ... Hope For The Warriors® in support of military families ... is a national nonprofit dedicated to restoring a sense ... for our service members and our military families. ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 For the ... specialist used DNA sequencing from a single cell extracted ... that ran in the father’s family. Double-board certified expert ... Springs and Newport Beach, then implanted only the healthy ... , “The world of In Vitro Fertilization has taken ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 Wright & ... Miami ordered Boston Scientific Corp. to pay a total ... who filed bladder mesh lawsuits after they suffered injuries ... company’s Pinnacle transvaginal mesh implant. Bloomberg reported that jurors ... defectively designed and the company failed to warn physicians ...
Breaking Medicine News(10 mins):Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2Health News:IVF Specialist From American Reproductive Centers Performs World's First DNA Sequencing On Single Cell So Defected Genes Won't Be Passed To Future Generations 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 3Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 4
... Feb. 1 (HealthDay News) -- Among injection drug users, new ... two decades, but the number of new infections from the ... new study reports. The findings suggest that efforts -- ... to prevent blood-borne transmission of infectious diseases have been successful ...
... February 1, 2011 While the overall death rate for ... to have higher death rates and shorter survival of any ... The findings come from Cancer Facts & Figures for African ... two years by the American Cancer Society. The higher ...
... circulating DNA may indicate faster progression of lung cancer ... in the February edition of the Journal of ... Association for the Study of Lung Cancer (IASLC). ... presented more free DNA in the blood than healthy ...
... , MONDAY, Jan. 31 (HealthDay News) -- X-rays, CT scans ... back pain, but often these tests are unnecessary, suggests new ... more, these imaging tests have the potential to cause harm ... -- such as a bulging disc -- that may not ...
... Steven Reinberg HealthDay Reporter , MONDAY, Jan. 31 ... having a stroke, they appear to have better odds of ... This finding might seem odd since conventional wisdom says black ... medical care in general. However, the same trend has been ...
... services that supports California,s low-income, disabled elderly is fragile, ... independent lives in their own homes, according to a ... Research. This policy note reports the ... lives and challenges encountered by several dozen representative older ...
Cached Medicine News:Health News:Infectious Disease Experts Call for More Focus on Hepatitis C 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 3Health News:High levels of circulating DNA may signal faster progression of lung cancer 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 3Health News:Survival After Stroke Better for Blacks 2Health News:Survival After Stroke Better for Blacks 3Health News:Aging safely at home? California's disabled elderly are barely holding on 2Health News:Aging safely at home? California's disabled elderly are barely holding on 3
(Date:11/17/2014)... PARK, Calif. , Nov. 17, 2014 ... company in the emerging field of regenerative medicine, today ... President of Research and Development, will participate in a ... for Regenerative Medicine (CIRM) discussing the latest progress in ... The CIRM Google Hangout session is scheduled for ...
(Date:11/17/2014)... Wilson Therapeutics AB, a development stage biopharmaceutical company, ... study to evaluate efficacy and safety of its lead ... disorder and designated orphan disease, in which the body ... delighted to proceed with this important clinical study in ... development program for WTX101," said David Clark , ...
(Date:11/17/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ... their 2013 collaboration, option, and license agreement to co-develop ... as their research collaboration in prostate cancer. All of ... the product to other parties, will be returned to ... phase I clinical trial in the first half of ...
Breaking Medicine Technology:Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 2Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 4Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 5
... NEW YORK, June 2, 2011 Citeline, the world,s ... recently completed a comprehensive review of clinical trial starts ... patterns in drug development. Over the one-year review period ... trials were initiated in the oncology sector, more than ...
... Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today ... Trademark Office of Patent Application Serial No. 12/549458 ... This follows the UK issuance which was granted ... patent estate. The patent covers the ...
Cached Medicine Technology:Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 2Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 3Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
... is the third diagnostic,hepatitis assay approved by ... being run in a random,access format on ... the laboratory staff,can run an anti-HCV test ... 27 assays, and provide anti-HCV,test results in ...
... a non-reactive quality assurance reagent in assays ... 1 (anti-HIV-1), antibody to human immunodeficiency virus ... virus type 1 (HIV-1 Ag), antibody to ... to hepatitis C virus (anti-HCV), immunoglobulin M ...
Medicine Products: